S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
UK
LSE
Beximco Pharma (BXP)
Beximco Pharma (BXP) Financials

Beximco Pharma (BXP)

34.00

0.50

( 1.49% )

Updated: 02:15:34

Delayed by 15 minutes

Beximco Pharma Financial Summary

The current BXP market cap is 151.68M. The company's latest EPS is BDT and P/E is N/A.

Income Statement

Year End June 29 2023	2019	2020	2021	2022	2023
	BDT (BDT)	BDT (BDT)	BDT (BDT)	BDT (BDT)	BDT (BDT)
Total Revenue	22.82B	25.61B	29.49B	34.67B	39.27B
Operating Income	5.04B	5.99B	7.09B	6.9B	7.22B
Net Income	3.03B	3.51B	5.13B	5.12B	4.61B

Balance Sheet

Year End June 29 2023	2019	2020	2021	2022	2023
	BDT (BDT)	BDT (BDT)	BDT (BDT)	BDT (BDT)	BDT (BDT)
Total Assets	49.21B	50.12B	52.25B	66.15B	69.16B
Total Liabilities	19.35B	17.32B	14.88B	21.51B	21.54B
Total Equity	29.86B	32.8B	37.36B	44.64B	47.62B

Cash Flow

Year End June 29 2023	2019	2020	2021	2022	2023
	BDT (BDT)	BDT (BDT)	BDT (BDT)	BDT (BDT)	BDT (BDT)
Operating	2.96B	5.54B	6.02B	5.21B	6.08B
Investing	-4.51B	-1.95B	-2.52B	-7.68B	-2.62B
Financing	1.77B	-3.57B	-3.46B	2.62B	-3.56B

Stats and Ratios

Market Cap	151.68M
Price to Earnings Ratio	N/A
Price to Sales Ratio	0
Price to Cash Ratio	0
Price to Book Ratio	0
Dividend Yield	-

Share Statistics

Shares Outstanding	446.11M
Average Volume (1 week)	0
Average Volume (1 Month)	0
52 Week Change	-
52 Week High	-
52 Week Low	-
Spread (Intraday)	2 (5.71%)

Company Info

Company Name	Beximco Pharma
Address	17 dhanmondi r/a, road no. 2 dhaka city 1205
Website	https://www.beximcopharma.com
Industry	pharmaceutical generic (H22)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions